Arcas strengthens its European Team

We are very pleased to welcome Jan Willem (JW) Gommers, MSc to the leadership of The Arcas Group as Director, Business Development Europe. He joins with more than 15 years of international and local experience in the biopharma industry, established through a variety of roles with increased responsibility.

Earlier in his career, Jan Willem held several management positions with Organon, Amgen and Astrazeneca. Most recently, JW was Business Unit Manager Oncology at GlaxoSmithKline, successfully launching GSK Oncology in The Netherlands. In this role, he directed the market access, sales and product management functions for the Oncology & Hematology portfolio and carried full P&L responsibility. Subsequently, Jan Willem founded Blue Ocean, a Management Consulting company.

“I am excited to have Jan Willem join our team. He is a consummate professional with high energy, great insight and a very significant network in biopharma. JW is a great asset to our company and our clients,” says Jan Heybroek, President of The Arcas Group.

Jan Willem may be reached directly at [email protected]

Arcas in the news

Since the summer, key staff of The Arcas Group have been featured in several news articles and interviews. The publications and topics covered provide a good indication of the breadth and depth of our team and insights.

In chronological order, Arcas was featured as follows:
* Oncology Business Review July-August 2010: original article on factors driving use of oncology biomarkers (article, additional research on pg 26, 28)
* Pharmaceutical Executive September 2010: quote in article on Gilead (article, quote is on page 50)
* Pharmaceutical Executive October 2010: in-depth interview on the changing landscape of payers and pharma with a focus on oncology (article). For a downloadable version, you may click here.

We look forward to working with you in addressing your strategic marketing and oncology intelligence challenges. Please contact us here for more information on our Business Optimizer and Outcome Optimizer services or to schedule a demo of our total oncology intelligence platform, MDoutlook.